Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Phesgo 600mg/600mg Solution for Injection
Phesgo 600mg/600mg Solution for Injection is a specialized medication indicated for the treatment of breast cancer, offering a combination therapy to effectively target cancer cells and inhibit their proliferation.
Uses of Phesgo 600mg/600mg Solution for Injection
Phesgo 600mg/600mg Solution for Injection is used for:
Treatment of HER2-positive breast cancer.
Administration as part of combination therapy in early and metastatic breast cancer settings.
Benefits of Phesgo 600mg/600mg Solution for Injection
Provides dual-targeted therapy with pertuzumab and trastuzumab, effectively killing HER2-positive cancer cells.
Reduces the risk of cancer recurrence and improves overall survival rates.
Offers a convenient subcutaneous injection, minimizing treatment duration and enhancing patient comfort.
Mechanism of Action of Phesgo 600mg/600mg Solution for Injection
Phesgo 600mg/600mg Solution for Injection combines pertuzumab and trastuzumab, monoclonal antibodies that target different regions of the HER2 receptor. Pertuzumab inhibits HER2 dimerization, blocking cell signaling pathways crucial for cancer cell growth. Trastuzumab binds to HER2 receptors, promoting antibody-dependent cellular cytotoxicity and inducing apoptosis in HER2-positive cancer cells.